PUBLICATION

Orthotopic models of pediatric brain tumors in zebrafish

Authors
Eden, C.J., Ju, B., Murugesan, M., Phoenix, T.N., Nimmervoll, B., Tong, Y., Ellison, D.W., Finkelstein, D., Wright, K., Boulos, N., Dapper, J., Thiruvenkatam, R., Lessman, C.A., Taylor, M.R., Gilbertson, R.J.
ID
ZDB-PUB-140513-115
Date
2015
Source
Oncogene   34(13): 1736-42 (Journal)
Registered Authors
Lessman, Charles, Taylor, Michael
Keywords
none
MeSH Terms
  • Animals
  • Brain Neoplasms/pathology*
  • Child
  • Disease Models, Animal*
  • Drug Discovery
  • Glioma/pathology*
  • High-Throughput Screening Assays
  • Humans
  • Mice
  • Neoplasm Transplantation
  • Transcriptome
  • Transplantation, Heterologous
  • Zebrafish
PubMed
24747973 Full text @ Oncogene
Abstract
High-throughput screens (HTS) of compound toxicity against cancer cells can identify thousands of potential new drug-leads. But only limited numbers of these compounds can progress to expensive and labor-intensive efficacy studies in mice, creating a 'bottle neck' in the drug development pipeline. Approaches that triage drug-leads for further study are greatly needed. Here we provide an intermediary platform between HTS and mice by adapting mouse models of pediatric brain tumors to grow as orthotopic xenografts in the brains of zebrafish. Freshly isolated mouse ependymoma, glioma and choroid plexus carcinoma cells expressing red fluorescence protein were conditioned to grow at 34 °C. Conditioned tumor cells were then transplanted orthotopically into the brains of zebrafish acclimatized to ambient temperatures of 34 °C. Live in vivo fluorescence imaging identified robust, quantifiable and reproducible brain tumor growth as well as spinal metastasis in zebrafish. All tumor xenografts in zebrafish retained the histological characteristics of the corresponding parent mouse tumor and efficiently recruited fish endothelial cells to form a tumor vasculature. Finally, by treating zebrafish harboring ERBB2-driven gliomas with an appropriate cytotoxic chemotherapy (5-fluorouracil) or tyrosine kinase inhibitor (erlotinib), we show that these models can effectively assess drug efficacy. Our data demonstrate, for the first time, that mouse brain tumors can grow orthotopically in fish and serve as a platform to study drug efficacy. As large cohorts of brain tumor-bearing zebrafish can be generated rapidly and inexpensively, these models may serve as a powerful tool to triage drug-leads from HTS for formal efficacy testing in mice.Oncogene advance online publication, 21 April 2014; doi:10.1038/onc.2014.107.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping